Automatic quantification of HER2 gene amplification in invasive breast cancer from chromogenic in situ hybridization whole slide images

Abstract. Human epidermal growth factor receptor 2 (HER2), a transmembrane tyrosine kinase receptor encoded by the ERBB2 gene on chromosome 17q12, is a predictive and prognostic biomarker in invasive breast cancer (BC). Approximately 20% of BC are HER2-positive as a result of ERBB2 gene amplification and overexpression of the HER2 protein. Quantification of HER2 is performed routinely on all invasive BCs, to assist in clinical decision making for prognosis and treatment for HER2-positive BC patients by manually counting gene signals. We propose an automated system to quantify the HER2 gene status from chromogenic in situ hybridization (CISH) whole slide images (WSI) in invasive BC. The proposed method selects untruncated and nonoverlapped singular nuclei from the cancer regions using color unmixing and machine learning techniques. Then, HER2 and chromosome enumeration probe 17 (CEP17) signals are detected based on the RGB intensity and counted per nucleus. Finally, the HER2-to-CEP17 signal ratio is calculated to determine the HER2 amplification status following the ASCO/CAP 2018 guidelines. The proposed method reduced the labor and time for the quantification. In the experiment, the correlation coefficient between the proposed automatic CISH quantification method and pathologist manual enumeration was 0.98. The p-values larger than 0.05 from the one-sided paired t-test ensured that the proposed method yields statistically indifferent results to the reference method. The method was established on WSI scanned by two different scanners. Through the experiments, the capability of the proposed system has been demonstrated.

[1]  Ian T. Young,et al.  An Analysis Technique for Biological Shape. I , 1974, Inf. Control..

[2]  D. Larsimont,et al.  Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. , 2000, The American journal of pathology.

[3]  Ed Schuuring,et al.  Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study , 2015, PloS one.

[4]  A. Ruifrok,et al.  Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.

[5]  A. V. D. van den Brule,et al.  Detection of HER2 Amplification in Breast Carcinomas: Comparison of Multiplex Ligation-Dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with Automated Spot Counting , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[6]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[7]  Caroline Diorio,et al.  Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens , 2013, Diagnostic Pathology.

[8]  Weixin Xie,et al.  Two-stage hybrid feature selection algorithms for diagnosing erythemato-squamous diseases , 2013, Health Inf. Sci. Syst..

[9]  Arvydas Laurinavicius,et al.  Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue , 2017, BioMed research international.

[10]  H. Netten,et al.  FISH and chips: automation of fluorescent dot counting in interphase cell nuclei. , 1997, Cytometry.

[11]  Weixin Xie,et al.  Novel Hybrid Feature Selection Algorithms for Diagnosing Erythemato-Squamous Diseases , 2012, HIS.

[12]  M. A. Seguí,et al.  HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred cases. , 2006, Breast.

[13]  J Lundin,et al.  A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals , 2007, Journal of Clinical Pathology.

[14]  Kazuhiko Hamamoto,et al.  Detection and Classification of Overlapping Cell Nuclei in Cytology Effusion Images Using a Double-Strategy Random Forest , 2018, Applied Sciences.

[15]  Srdjan Stankovic,et al.  Multifractal-based nuclei segmentation in fish images , 2017, Biomedical microdevices.

[16]  John M S Bartlett,et al.  Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. , 2018, Archives of pathology & laboratory medicine.

[17]  Chin-Chen Chang,et al.  A shape recognition scheme based on relative distances of feature points from the centroid , 1991, Pattern Recognition.